mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
7e-07 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-06 |